Efficacy and safety of repetitive Transcranial Magnetic Stimulation and transcranial Direct Current Stimulation in memory deficits in patients with Alzheimer's disease: Meta-analysis and systematic review

Elsevier,

International Journal of Clinical and Health Psychology, Volume 24, Issue 2, April–June 2024, 100452

This study indicates that both repetitive transcranial magnetic stimulation (rTMS) and transcranial direct current stimulation (tDCS) can improve memory in Alzheimer�s disease (AD) patients, with rTMS being more effective in the frontal regions and tDCS in the temporal areas, supporting their safety and potential for enhancing cognitive functions mainly linked to memory

Read more

Category:

Articles

Tags:

Health and wellbeing, Global

Hypertension & dementia: Pathophysiology & potential utility of antihypertensives in reducing disease burden

Elsevier,

Pharmacology and Therapeutics, Volume 253, January 2024
Article discusses the relationship between hypertension and dementia, and the potential utility of antihypertensive medications in reducing the risk of cognitive decline and dementia. It concludes that mid-life hypertension is a risk factor for both vascular dementia and Alzheimer's disease, and that further research is needed to clarify the neuroprotective properties of different antihypertensive drug classes.
Read more

Category:

Articles

Tags:

Health and wellbeing; Health and population, Global

Evaluation of Depression and Perceived Voice Handicap Through Self-Report in Individuals With Alzheimer's Disease

Elsevier,

Journal of Voice, Volume , 2024
This study aims to assess depression and perception of vocal handicap in individuals with and without early-stage Alzheimer's disease (AD) using a self-report method. Depression is commonly observed in elderly individuals and can significantly impact their quality of life, management of chronic diseases, and daily and instrumental activities. In elderly individuals with AD, the risk of depression is twice as high compared to those without Alzheimer's.
Read more

Category:

Articles

Tags:

Health and wellbeing, Global

Natural Molecules in Neuroprotection and Neurotoxicity: Chapter 70 - Neuroprotection induced by terpenes: focus on Alzheimer’s disease and Parkinson’s disease

Elsevier,

Natural Molecules in Neuroprotection and Neurotoxicity, 2024, pp 1669-1678
This content aligns with Goal 3: Good Health and Wellbeing and Goal 9: Industry, Innovation, and Infrastructure by identifying potential nutraceutical applications of bioactive compounds for prevention and treatment of Alzheimer's Disease.
Read more

Category:

Book chapters

Tags:

Health and population; Health and wellbeing, Global

Nutraceutical Fruits and Foods for Neurodegenerative Disorders: Chapter 20 - Nutraceutical interventions in Alzheimer's disease

Elsevier,

Nutraceutical Fruits and Foods for Neurodegenerative Disorders, 2024, pp 379-404
This content aligns with Goal 3: Good Health and Wellbeing and Goal 9: Industry, Innovation, and Infrastructure by considering the neuroprotective properties of nutraceuticals such as soy, peanuts, and ginsenoside Rg1.
Read more

Category:

Book chapters

Tags:

Health and population; Health and wellbeing, Global

Fecal microbiota transplantation: A new strategy to delay aging

Elsevier,

hLife, Volume 1, November 2023
Fecal microbiota transplantation (FMT) from young donors can delay aging and improve health outcomes by restoring gut microbiota balance, with potential therapeutic benefits for neurodegenerative diseases like Alzheimer's through the gut–brain axis. However, challenges remain in donor selection and establishing effective transplantation protocols.
Read more

Category:

Articles

Tags:

Health and wellbeing, Global

Impact and Implications of Neurocognitive Dysfunction in the Management of Ischemic Heart Failure

Elsevier,

Journal of the Society for Cardiovascular Angiography and Interventions, Volume 2, 1 November 2023
Neurocognitive dysfunction is common in heart failure (HF), and is independently associated with worse outcomes including mortality, rehospitalization, and reduced quality of life. It is paramount to raise awareness of the neurocognitive consequences in ischemic HF and devise strategies for recognition and prevention as an important target of patient management and personalized decision making that contributes to patient outcomes. This review outlines the current evidence and gaps in our understanding of neurocognitive dysfunction in HF and their implications on selection of revascularization strategies in patients with ischemic HFrEF.
Read more

Category:

Articles

Tags:

Health and wellbeing, Global

Partner content

United Nations Global Compact

SDG Fly the Flag 2026

RELX
SDG flag flying against a blue sky

As we enter the ninth year since the adoption of the UN Sustainable Development Goals (SDGs) in 2015, the pressing need to meet these ambitious objectives becomes ever more evident.

Read more
Sep 2026
25

Category:

Events
Global

Older adults’ goals of care in the emergency department setting: A qualitative study guided by the 4Ms framework

Elsevier,

JACEP Open, Volume 4, August 2023
This study seeks to identify what matters to older adults (60 years and older) presenting to the emergency department (ED) and the challenges or concerns they identify related to medication, mobility, and mentation to inform how the 4Ms framework could improve care of older adults in the ED setting.
Read more

Category:

Articles

Tags:

Health and wellbeing, North America

World Alzheimer's Day 2026

RELX
World Alzheimer's Day 2023

 World Alzheimer's Day: How to Get Involved and Make a Positive Impact

Read more
Sep 2026
21

Category:

Events

Tags:

Health and population; Health and wellbeing, Global

Pages

Content
image/svg+xml
View global news
View useful links